INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

For the key trials, our articles and recipes, read the Weight & Appetite desk →

1,735 studies · page 36 of 73

2016 / Narrative review

Daily physical activity and structured exercise generally produce beneficial effects on body weight without offsetting compensatory responses.

This narrative review evaluated scientific literature regarding the role of physical activity in body weight regulation and energy balance. Based on the existing literature, daily physical activity and structured exercise in adequate amounts increased total daily energy expenditure and created an acute energy deficit. In most instances, this occurred without compensatory declines in non-exercise physical activity or energy expenditure, and without compensatory increases in energy intake. The authors noted gaps in the literature, including a lack of adequately powered clinical trials with rigorous assessments of energy intake and expenditure across diverse populations, volumes, and intensities.

Shook RP Expert Rev Endocrinol Metab, 2016. PMID 30058919

2015 / Narrative review

Higher adiposity was associated with frontal gray matter atrophy across all ages, and parietal and temporal atrophy in middle-aged and older adults.

This review evaluated studies assessing obesity and gray or white matter volumes globally or in specific regions of interest. Across all ages, higher adiposity was consistently associated with frontal gray matter atrophy, particularly in the prefrontal cortex. In children and adults under 40 years of age, most studies found no link with occipital or parietal gray matter volumes, while temporal lobe results were mixed. In middle-aged and older adults, higher adiposity was linked to parietal and temporal gray matter atrophy, while findings for the precuneus, posterior cingulate, and hippocampus were mixed. No clear association was observed with global or regional white matter in any age group.

Shows an association, not proof of cause and effect.

Willette AA, Kapogiannis D Ageing Res Rev, 2015. PMID 24768742

2015 / Narrative review

A review evaluates scientific evidence for 9 myths and 10 common presumptions surrounding obesity and weight loss.

This review evaluates 9 myths (strongly held beliefs contradicted by scientific evidence) and 10 presumptions (beliefs lacking scientific evidence to support them) in obesity research. The authors examine topics including rapid weight loss, realistic goals, physical education, breastfeeding, breakfast consumption, fruit and vegetable intake, snacking, portion size, and drinking water. For each topic, the paper details evidence directly supporting or refuting the belief, incorporating findings from randomized controlled trials when available, and provides suggestions to limit the spread of unsubstantiated beliefs.

Casazza K, Brown A, Astrup A, et al. Crit Rev Food Sci Nutr, 2015. PMID 24950157

2015 / Narrative review

Lifestyle modifications are effective in improving or restoring erectile function in individuals with obesity or metabolic syndrome.

This review evaluated modifiable risk factors for erectile dysfunction (ED), including diet, physical activity, smoking, alcohol use, and excess weight. These factors are linked to a pro-inflammatory state that contributes to endothelial dysfunction by reducing nitric oxide availability. In clinical trials, lifestyle changes were reported to ameliorate ED or restore absent ED in individuals with obesity or metabolic syndrome.

Maiorino MI, Bellastella G, Esposito K Asian J Androl, 2015. PMID 25248655

2015 / Narrative review

A review discusses subpopulations where obesity may not be harmful or where weight loss might not always improve health.

This review takes a devil's advocate position to discuss subgroups of obese individuals who may not be adversely affected by their weight, or who may even benefit from higher adiposity. It examines situations where weight loss per se may not be the most appropriate recommendation. Specifically, it addresses adults with established cardiovascular disease, type 2 diabetes, weight cyclers, metabolically healthy obese adults, youth, older adults, and highly fit obese individuals.

Brown RE, Kuk JL Obes Rev, 2015. PMID 25410935

2015 / Narrative review

The obesity epidemic is associated with increased cancer incidence and may lead to poor cancer outcomes via metabolic and signaling pathways.

This review examines the relationship between the obesity epidemic and cancer incidence and outcomes. Obesity is associated with increased cancer incidence at a population level and may lead to poor cancer outcomes, though concurrent decreases in overall cancer mortality may reflect improvements in diagnosis and treatment. Biologically, active adipose tissue secretes estrogens, adipokines, and cytokines, and adipose reprogramming may lead to insulin resistance, impacting cancer progression locally, systemically, through pathways such as PI3K and JAK-STAT, or via the tumor microenvironment.

Shows an association, not proof of cause and effect.

Goodwin PJ, Stambolic V Annu Rev Med, 2015. PMID 25423596

2015 / Narrative review

A review indicates inflamed adipose tissue and dyslipidemia play pivotal roles beyond joint loading in obesity-induced osteoarthritis.

This review examines the mechanisms linking obesity to osteoarthritis. It evaluates the historical view of altered joint loading and wear and tear alongside the impact of disturbed lipid metabolism, low-grade inflammation, and adipokines on joint tissues. The authors conclude that inflamed adipose tissue and dyslipidemia play key roles in obesity-induced osteoarthritis, extending beyond excessive mechanical loading.

Thijssen E, van Caam A, van der Kraan PM Rheumatology (Oxford), 2015. PMID 25504962

2015 / Hypothesis / narrative review

The personal fat threshold hypothesis proposes that exceeding an individual fat capacity triggers type 2 diabetes independently of BMI.

Authors present the personal fat threshold (PFT) hypothesis to explain type 2 diabetes (T2DM) occurrence in normal-BMI individuals. Data from the UKPDS cohort of individuals diagnosed in the 1970s and 1980s showed a median BMI of 28 kg/m2, with one in three having a BMI under 25 kg/m2. The authors hypothesize that exceeding one's individual PFT triggers T2DM, and subsequent weight loss below this threshold permits return to normal glucose control regardless of whether the person is classified as obese by BMI.

Taylor R, Holman RR Clin Sci (Lond), 2015. PMID 25515001

2015 / Systematic literature review

Regular self-weighing was linked to greater weight loss without adverse psychological outcomes in adults seeking weight loss.

A systematic review of 17 prospective, longitudinal studies evaluated the relationships between regular self-weighing, weight change, and psychological outcomes in adults seeking weight loss. Regular self-weighing was associated with more weight loss and was not associated with adverse psychological outcomes such as depression or anxiety. The effect sizes of the association between self-weighing and weight change varied across studies, as did the reported frequency of self-weighing.

Shows an association, not proof of cause and effect.

Zheng Y, Klem ML, Sereika SM, et al. Obesity (Silver Spring), 2015. PMID 25521523

2015 / Critical narrative review

There is very little clinical evidence and no randomized controlled trials supporting commercial detox diets for toxin elimination or weight management.

This review examined the necessity, components, efficacy, and potential dangers of detox diets. Very little clinical evidence supports these diets; a few clinical studies reported that commercial detox diets enhance liver detoxification and eliminate persistent organic pollutants, but were hampered by small sample sizes and flawed methodologies. No randomised controlled trials have assessed commercial detox diets in humans, and evidence for specific foods (such as coriander, nori, and olestra) is primarily from animal studies.

Klein AV, Kiat H J Hum Nutr Diet, 2015. PMID 25522674

2015 / Editorial

An editorial outlines several reasons why anti-obesity pharmacological treatments remain stigmatized.

This editorial discusses why anti-obesity medications are stigmatized despite being useful tools alongside lifestyle modifications. Identified reasons include the failure of short-term medication use to achieve long-term results, the common perception of obesity as a lifestyle choice, and difficulties treating obesity in primary care. Additional factors cited are less than desired weight-loss results, misuse of medications for cosmetic reasons, and an unfavorable history of other anti-obesity drugs withdrawn in previous decades.

Halpern B, Halpern A Expert Opin Drug Saf, 2015. PMID 25529104

2015 / Narrative review

Intermittent and alternate-day fasting show potential for promoting weight loss, though hunger may be a limiting factor for long-term adherence.

This review evaluates whether fasting regimens, such as alternate-day fasting or the 5:2 diet, represent effective strategies or short-term dieting trends for obesity management. Intermittent fasting approaches appear to promote weight loss without complex daily calorie counting, but they are linked to hunger, which can hinder ongoing dietary restriction. The long-term effects of chronic food restriction in humans remain unclear, and no single dietary intervention will solve the obesity epidemic.

Johnstone A Int J Obes (Lond), 2015. PMID 25540982

2015 / Narrative review

Clinical trials examining the metabolic effects of resveratrol have yielded mixed results.

This review evaluates the metabolic effects and mechanism of action of resveratrol, a polyphenol found in plant-based foods such as red wine. Resveratrol has been reported to have diverse healthful effects, including improving mitochondrial function and protecting against obesity, type-2 diabetes, cardiovascular dysfunction, and cancer cell growth. However, clinical trials investigating its metabolic effects have produced mixed results, leaving several controversies unresolved.

Bitterman JL, Chung JH Cell Mol Life Sci, 2015. PMID 25548801

2015 / Clinical practice guideline with systematic reviews

Approved weight-loss medications are useful adjuncts to lifestyle changes for patients unsuccessful with diet and exercise alone, according to guidelines.

An Endocrine Society-appointed Task Force developed evidence-based clinical practice guidelines for the pharmacological management of obesity using the GRADE system and two systematic reviews. The guidelines concluded that medications approved for chronic weight management serve as useful adjuncts to lifestyle changes for patients who have been unsuccessful with diet and exercise alone. Furthermore, because many drugs prescribed for conditions such as diabetes and depression impact weight, prescribing medications with favorable weight profiles can aid obesity prevention and management.

Apovian CM, Aronne LJ, Bessesen DH, et al. J Clin Endocrinol Metab, 2015. PMID 25590212

2015 / Roundtable discussion summary report

A roundtable discussion highlighted that current candy intake levels are not associated with weight gain or cardiovascular disease risk in children and adults.

A roundtable of behavioral nutrition experts, researchers, and nutrition educators reviewed candy consumption patterns, related health outcomes, and behavioral strategies to promote moderation. Although 97% of Americans report eating candy at least once yearly, only about one-fourth of the US population aged ≥2 years consumes it on a given day, contributing a relatively small proportion of calories, added sugars, and saturated fat. Recent research cited suggests current candy consumption levels are not associated with weight gain or cardiovascular disease risk in children and adults. The panel noted that restricting access to palatable foods may have negative consequences and identified behavioral and environmental strategies as key steps to promote moderation.

Shows an association, not proof of cause and effect.

Duyff RL, Birch LL, Byrd-Bredbenner C, et al. Adv Nutr, 2015. PMID 25593156

2015 / Narrative review

Obesity was linked to a loss of white matter integrity, showing inverse associations between BMI and fractional anisotropy across various brain tracts.

This review evaluated the relationship between obesity and brain alterations assessed by diffusion tensor imaging (DTI). Altogether, reviewed studies demonstrated a loss of white matter integrity with obesity-related factors, particularly in tracts within the limbic system and those connecting the temporal and frontal lobes. Multiple studies found an inverse association between BMI and fractional anisotropy in the corpus callosum, fornix, cingulum, and corona radiata in elderly, young adults, and children. In addition, significant interactions between BMI and age suggested accelerated aging of white matter structure in obesity.

Shows an association, not proof of cause and effect.

Kullmann S, Schweizer F, Veit R, et al. Obes Rev, 2015. PMID 25676886

2015 / Narrative review

No country has yet reversed its obesity epidemic, requiring systemic regulatory actions to break reciprocal individual-environmental cycles.

This Lancet Series paper reviews global regulatory and non-regulatory actions taken to address obesity and examines barriers to progress. It notes that despite isolated improvements, no country has reversed its obesity epidemic. The authors challenge common dichotomies surrounding obesity and argue that modern food environments exploit biological, psychological, social, and economic vulnerabilities to promote unhealthy foods. They conclude that government regulation, along with industry and civil society efforts, is necessary to dismantle these cycles.

Roberto CA, Swinburn B, Hawkes C, et al. Lancet, 2015. PMID 25703111

2015 / Narrative review

A review highlights that lifestyle behavior change is essential for weight loss, noting over 50% of bariatric surgery patients regain weight without it.

This review examines the use of lifestyle medicine versus bariatric surgery (BSx) to treat obesity in the United States. It notes that BSx is medically complex, carries risks including major complications and death, and that over 50% of BSx patients regain weight without lifestyle modification. The author suggests conclusions favoring BSx over nonsurgical management are flawed when lifestyle management is not identical between cohorts, and advocates for resources supporting lifestyle behavior change programs.

Trilk JL, Kennedy AB Curr Sports Med Rep, 2015. PMID 25757003

2015 / Narrative review

Electric light, particularly at night, disrupts human circadian rhythms and may play an etiologic role in diseases like obesity, diabetes, and certain cancers.

This review examines how modern electric lighting creates inadequate daytime light indoors and excessive light at night, disrupting human circadian rhythmicity. This disruption alters sleep/wake cycles, core body temperature, hormone regulation, and gene expression patterns. Epidemiological and mechanistic evidence suggests light-induced circadian disruption may contribute to modern conditions such as breast and prostate cancers, obesity, diabetes, and depression, with potential pathways involving melatonin suppression, circadian gene expression, and metabolism influenced in part by heme iron intake and distribution.

Shows an association, not proof of cause and effect.

Stevens RG, Zhu Y Philos Trans R Soc Lond B Biol Sci, 2015. PMID 25780233

2015 / Commentary / narrative review

A commentary discusses findings that non-caloric artificial sweeteners may induce glucose intolerance by altering the gut microbiome.

Non-caloric artificial sweeteners (NAS) are widely consumed to combat weight gain and diabetes, but their role in promoting metabolic derangements remains controversial. The authors recently demonstrated that NAS consumption can induce glucose intolerance in mice and distinct human subsets through functional alterations of the gut microbiome. This commentary reviews these findings alongside other works and outlines the challenges in understanding how NAS impacts human health.

Suez J, Korem T, Zilberman-Schapira G, et al. Gut Microbes, 2015. PMID 25831243

2015 / Narrative review

Newer weight management medications aid weight loss and maintenance, with varying positive and potentially negative cardiometabolic effects.

Since the 1980s, obesity prevalence has nearly doubled globally, with treatments including lifestyle modification, medications, and surgery. This review discusses the mechanisms and cardiometabolic implications of newly approved next-generation weight management medications. These medications demonstrate efficacy in initial weight management and long-term maintenance, while showing varying effects on diabetes and cardiovascular risks.

Wharton S, Serodio KJ Curr Cardiol Rep, 2015. PMID 25894803

2015 / Narrative review / hypothesis

Authors hypothesize the ketogenic diet may facilitate fat loss without negatively affecting strength and power performance in sports.

The ketogenic diet is widely utilized for weight loss and occasionally for disease therapy. Weight control is frequently required in sports such as boxing, weightlifting, and wrestling, where the ketogenic diet is typically not considered. The authors hypothesize that the ketogenic diet could be applied to achieve fat loss without negatively impacting strength or power performance.

Paoli A, Bianco A, Grimaldi KA Exerc Sport Sci Rev, 2015. PMID 25906427

2015 / Narrative review of acute and long-term feeding studies and meta-analyses

Higher-protein diets of 1.2 to 1.6 g/kg/d improve weight management, appetite control, and cardiometabolic risk factors, especially with dietary compliance.

This review examines literature on mechanisms following acute protein consumption and clinical outcomes from long-term, higher-protein diets. Meta-analyses of shorter-term, tightly controlled feeding studies showed greater weight loss, fat mass loss, lean mass preservation, and reductions in triglycerides, blood pressure, and waist circumference with higher-protein diets. Acute trials confirmed modest satiety effects without affecting energy intake at the next meal, while longer-term studies yielded conflicting findings largely driven by dietary compliance. The evidence suggests diets containing 1.2 to 1.6 g protein · kg-1 · d-1 (with at least ~25-30 g/meal) provide improvements in appetite, weight management, and cardiometabolic factors.

Leidy HJ, Clifton PM, Astrup A, et al. Am J Clin Nutr, 2015. PMID 25926512

2015 / Historical review and narrative summary

Abdominal fat distribution is linked to increased insulin resistance and higher risk of type 2 diabetes and cardiovascular disease.

An early 1980s analysis of the metabolic profiles of 930 men and women showed that an abdominal distribution of fat for a given BMI is associated with increased insulin resistance and risk of type 2 diabetes and cardiovascular disease. This correlation has since been validated across multiple studies, establishing waist circumference as a diagnostic criterion for metabolic syndrome. Visceral fat represents one of several ectopic fat depots utilized when subcutaneous adipose tissue cannot accommodate excess fat due to limited expandability.

Shows an association, not proof of cause and effect.

Smith U J Clin Invest, 2015. PMID 25932676